Loading...
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease
BACKGROUND: Biological therapies have been introduced for the treatment of chronic inflammatory diseases including rheumatoid arthritis (RA) and Crohn's disease (CD). The efficacy of biologics differs from patient to patient. Moreover these therapies are rather expensive, therefore treatment of...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4064310/ https://ncbi.nlm.nih.gov/pubmed/23809696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm463 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|